Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
41
41 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- REGN7508CenvacibartPhase 312 trials
Regeneron · Atrial Fibrillation (AF), Venous Thromboembolism (VTE), Venous Thromboembolism
- FianlimabREGN3767Phase 311 trials
Regeneron · Melanoma, Non-small Cell Lung Cancer, Hepatocellular Carcinoma
- OlatorepatideHS-20094Phase 38 trials
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Type 2 Diabetes, Overweight or Obesity, Overweight or Obesity Without Diabetes
- OdronextamabREGN1979, OrdsponoPhase 37 trials
Regeneron · Follicular Lymphoma (FL), Diffuse Large B-Cell Lymphoma (DLBCL), Relapsed/Refractory Follicular Lymphoma
- CemdisiranALN-CC5Phase 35 trials
Regeneron · Paroxysmal Nocturnal Hemoglobinuria, Generalized Myasthenia Gravis, Age-related Macular Degeneration (AMD)
- MibavademabREGN4461Phase 35 trials
Regeneron · Generalized Lipodystrophy, Functional Hypothalamic Amenorrhea, FHA
- REGN9933amrecibartPhase 35 trials
Regeneron · Atrial Fibrillation (AF), Peripheral Artery Disease (PAD), Venous Thromboembolism (VTE)
- ALN-CIDEBPhase 34 trials
Regeneron · Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis, MASLD
- CMP 001VidutolimodPhase 32 trials
Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer
- REGN1908FreneslerbartPhase 32 trials
Regeneron · Allergic Conjunctivitis
- REGN1909MevonlerbartPhase 32 trials
Regeneron · Allergic Conjunctivitis
- REGN5713BremzalerbartPhase 31 trial
Regeneron · Allergic Conjunctivitis
- REGN5715AtisnolerbartPhase 31 trial
Regeneron · Allergic Conjunctivitis
- UbamatamabREGN4018Phase 24 trials
Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
- REGN10597PD-1-IL2Ra-IL2 immunotherapyPhase 23 trials
Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
- REGN5678NezastomigPhase 23 trials
Regeneron · Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)
- REGN7075marlotamigPhase 23 trials
Regeneron · Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer
- ALN-PNPPhase 22 trials
Regeneron · Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Healthy Volunteers
- Fianlimab [Fixed ]Phase 22 trials
Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
- REGN4336Phase 22 trials
Regeneron · Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)
- REGN5459Vonsetamig, BCMAxCD3Phase 22 trials
Regeneron · Chronic Kidney Disease (CKD), Relapsed Multiple Myeloma, Refractory Multiple Myeloma
- REGN7544baloncibartPhase 22 trials
Regeneron · Postural Orthostatic Tachycardia Syndrome (POTS), Sepsis-Induced Hypotension
- ALN-6457ALN-PRNPPhase 21 trial
Regeneron · Prion Disease
- BNT116Phase 21 trial
Regeneron · Advanced Non-Small Cell Lung Cancer
- FDC fianlimabPhase 21 trial
Regeneron · Head and Neck Squamous Cell Carcinoma (HNSCC)
- Fixed cemiplimabPhase 21 trial
Regeneron · Melanoma
- LNP1265Phase 21 trial
Regeneron · Hemophilia B
- REGN13089-M404-M2980Phase 21 trial
Regeneron · Advanced Solid Tumors
- REGN13335Phase 21 trial
Regeneron · Pulmonary Arterial Hypertension (PAH)
- REGN15505Phase 21 trial
Regeneron · Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)
- REGN17372Phase 21 trial
Regeneron · Relapsed Refractory Multiple Myeloma (RRMM)
- REGN21353Phase 21 trial
Regeneron · Metastatic Castration-Resistant Prostate Cancer, mCRPC
- REGN22530Phase 21 trial
Regeneron · Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OHT)
- REGN5093davutamigPhase 21 trial
Regeneron · NSCLC
- REGN5381Phase 21 trial
Regeneron · Heart Failure
- REGN5668ubletamigPhase 21 trial
Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
- REGN7945Phase 21 trial
Regeneron · Relapsed/Refractory Multiple Myeloma
- REGN7999Phase 21 trial
Regeneron · Non-Transfusion Dependent Beta-Thalassemia (NTDT)
- REGN9220Phase 21 trial
Regeneron · Diffuse Large B-Cell Lymphoma (DLBCL)
- REGV131Phase 21 trial
Regeneron · Hemophilia B
- TrevogrumabREGN1033, GDF8Phase 21 trial
Regeneron · Obesity
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.